Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion type Assertion NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_head.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion description "[In neonates, CpG pretreatment led to a transient increase in expression of major histocompatibility complex class II (MHCII) and CD80 on CD11c-positive cells and gamma interferon (IFN-?) production by NK cells after RSV infection, suggesting that the protective effects may be mediated by antigen-presenting cells (APC) and NK cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_provenance.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion evidence source_evidence_literature NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_provenance.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion SIO_000772 22811525 NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_provenance.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion wasDerivedFrom befree-2016 NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_provenance.
- NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_assertion wasGeneratedBy ECO_0000203 NP998708.RA845E3sAAvePW5QE661Cx8QWz7rYnvBuig-LNUh4k2VA130_provenance.